Recent Acquisitions BioIVT has been actively acquiring companies in the biospecimen and research field. Recent acquisitions of PrecisionMed, Fidelis Research, XenoTech, and Cypex provide an opportunity to cross-sell services and expand the customer base.

Expansion of Offerings The launch of new centers like the Center for NeuroExcellence and products like GMP Grade Human AB Serum showcases BioIVT's commitment to innovation. Sales representatives can leverage these expanded offerings to attract new customers and upsell to existing ones.

Strong Financial Position With annual revenues between $100M - 1B and a funding of $45M, BioIVT exhibits financial stability and growth potential. This financial strength can be used as a selling point to assure customers of the company's sustainability and capacity for long-term partnerships.

Global Provider Status BioIVT is positioned as a global provider of biological specimens and research services. Its worldwide presence and unmatched portfolio make it an attractive partner for international clients seeking high-quality samples. Sales reps can capitalize on this global positioning to target new markets and expand the customer base.

Technology Integration Utilization of tech stacks like HubSpot CMS Hub and Google Tag Manager signifies BioIVT's embrace of technology for efficiency and customer engagement. Sales development representatives can highlight the company's technological savvy as a competitive edge, appealing to clients looking for advanced and streamlined services.